- Home
- NNBR vs ACOG Comparison
NNBR vs ACOG Comparison
Compare NNBR & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNBR
- ACOG
- Stock Information
- Founded
- NNBR 1980
- ACOG 2000
- Country
- NNBR United States
- ACOG Canada
- Employees
- NNBR N/A
- ACOG N/A
- Industry
- NNBR Industrial Machinery/Components
- ACOG
- Sector
- NNBR Industrials
- ACOG
- Exchange
- NNBR Nasdaq
- ACOG Nasdaq
- Market Cap
- NNBR 109.1M
- ACOG 129.6M
- IPO Year
- NNBR 1994
- ACOG N/A
- Fundamental
- Price
- NNBR $1.97
- ACOG $7.43
- Analyst Decision
- NNBR
- ACOG Strong Buy
- Analyst Count
- NNBR 0
- ACOG 1
- Target Price
- NNBR N/A
- ACOG $20.00
- AVG Volume (30 Days)
- NNBR 86.9K
- ACOG 89.9K
- Earning Date
- NNBR 10-29-2025
- ACOG 11-14-2025
- Dividend Yield
- NNBR N/A
- ACOG N/A
- EPS Growth
- NNBR N/A
- ACOG N/A
- EPS
- NNBR N/A
- ACOG N/A
- Revenue
- NNBR $433,709,000.00
- ACOG $4,586,341.00
- Revenue This Year
- NNBR N/A
- ACOG N/A
- Revenue Next Year
- NNBR $4.88
- ACOG $149.89
- P/E Ratio
- NNBR N/A
- ACOG N/A
- Revenue Growth
- NNBR N/A
- ACOG N/A
- 52 Week Low
- NNBR $1.58
- ACOG $3.75
- 52 Week High
- NNBR $4.67
- ACOG $11.54
- Technical
- Relative Strength Index (RSI)
- NNBR 34.86
- ACOG 41.71
- Support Level
- NNBR $1.93
- ACOG $6.40
- Resistance Level
- NNBR $2.10
- ACOG $7.62
- Average True Range (ATR)
- NNBR 0.11
- ACOG 0.61
- MACD
- NNBR -0.03
- ACOG -0.03
- Stochastic Oscillator
- NNBR 10.47
- ACOG 39.76
About NNBR NN Inc.
NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components. It operates in two business segments: mobile solutions and power solutions. The mobile solutions segment involves growth in the general industrial and automotive end markets. Its power solutions segment involves growth in the electrical and aerospace and defense end markets.
About ACOG Alpha Cognition Inc. Common Stock
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.